PODD vs RJF · P/E 34, rev $1.56B vs rev $15.91B
Insulet Corporation (PODD) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
RJF (RJF) common stock.
Latest reported PODD revenue for 2026-06-30 was $1.56B. Net income was $186.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. RJF currently screens at market cap $0.
Not investment advice. Open the PODD and RJF stock pages for the full models.
Not investment advice.